Topic: Charles Lieber

Charles Lieber comes up in 6 chapters across 6 episodes of The Higherside Chats Free Show, from June 2020 to March 2024.

June 2020 March 2024

Related topics

Ryan Cristian | Wag The Dog Reality, War News, & Control Tech Nightmares
• 51:47 - 55:19

Ryan Cristian | Wag The Dog Reality, War News, & Control Tech Nightmares

Bio-Digital Convergence and Nanotechnology in Medical Injections

The hosts discuss the work of Charles Lieber and Robert Langer, the co-founder of Moderna, regarding the development of virus-sized transistors and lipid nanoparticles. They explore the concept of "bio-digital convergence," where biology and technology blur, potentially allowing for the dispersal of biological proteins via geoengineering or injections. The segment suggests that the COVID-19 pandemic may have served as a massive experiment in human species-level technological integration and data harvesting.

charles lieberrobert langermodernaspike proteinbio-digital convergenceharvard
Dave Zed & Co. | Secret Science, Dark Web Findings, & The Black Goo
• 29:56 - 32:25

Dave Zed & Co. | Secret Science, Dark Web Findings, & The Black Goo

Nano Combing Techniques and the Intentionality of Belief

Dave Zed uses an analogy of a purse acting as a portal to explain anti-gravitic technology and the folding of space. He references a 2013 academic paper by Charles Lieber on "nano combing" to suggest that modern science is rediscovering ancient techniques used to cut rock with tuning forks. The segment concludes with the idea that an individual's intent and belief act as the center of their reality, effectively manifesting their physical experiences.

Alison McDowell | Graphene World Order, The Bio-Surveillance State & The Better Story
• 45:40 - 48:03

Alison McDowell | Graphene World Order, The Bio-Surveillance State & The Better Story

Neuralink Distractions and Non-Surgical Implants

Elon Musk’s Neuralink is characterized as a "red herring" designed to make people think they are safe if they avoid surgery. McDowell points to research by Charles Lieber at Harvard and "Teslaphoresis" at Rice University involving self-assembling carbon nanotubes as the real method for non-surgical neural interlacing.

Clint Richardson | Gain-Of-Function Research, Word Magic, & The Artificial Matrix
• 1:28:51 - 1:33:09

Clint Richardson | Gain-Of-Function Research, Word Magic, & The Artificial Matrix

Dr. Charles Lieber, Wuhan University, and Lab Leak Theories

The indictment of Harvard professor Dr. Charles Lieber is discussed in relation to his undisclosed work on nanotechnology at Wuhan University. The segment also mentions PCR inventor Cary Mullis and his critical views on Anthony Fauci prior to the COVID-19 pandemic.

charles lieberharvardnanotechnologywuhan universitycary mullis
Dr. Joseph P. Farrell | Election Fraud, Covert COVID Agendas & Nephilim Corpses
• 36:59 - 39:23

Dr. Joseph P. Farrell | Election Fraud, Covert COVID Agendas & Nephilim Corpses

Vaccine Safety Trials and Nanotechnology Links

The conversation turns to the risks of rushed vaccines, citing the historical precedent of the Salk polio vaccine and a recent Italian study finding unidentified nanoparticles in standard vaccines. They link these concerns to the arrest of Harvard professor Charles Lieber, a nanotechnology expert with ties to a Wuhan laboratory. Dr. Farrell posits that the COVID-19 pandemic may be an "op" designed to facilitate the injection of advanced technology.

Dr. Joseph P. Farrell | Engineered Unrest, Baal Gates, & The Plandemic
• 18:59 - 22:09

Dr. Joseph P. Farrell | Engineered Unrest, Baal Gates, & The Plandemic

Bill Gates, Nanotechnology, and the Wuhan Connection

The departure of Bill Gates from Microsoft and Berkshire Hathaway is linked to an alleged agenda involving injectable electromagnetic tracking systems. Joseph P. Farrell discusses the arrest of Harvard's Dr. Charles Lieber and his connections to nanotechnology research in Wuhan, China. The narrative connects Dr. Anthony Fauci's prior virus experimentation to the current outbreak, suggesting a transition of operations from the U.S. to Chinese labs.